PAS
RPRX icon

Park Avenue Securities’s Royalty Pharma RPRX Stock Holding History

Park Avenue Securities’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Buy
46,965
+1,117
+2% +$58.1K 0.02% 575
2026
Q1 		$2.2M Buy
45,848
+1,036
+2% +$45.4K 0.02% 523
2025
Q4 		$1.73M Buy
44,812
+935
+2% +$35.7K 0.01% 599
2025
Q3 		$1.55M Buy
+43,877
New +$1.59M 0.01% 691

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Park Avenue Securities's RPRX Position: Q2 2026 in Review

Park Avenue Securities increased its Royalty Pharma (RPRX) stake by 2.4% in Q2 2026, buying an estimated $58.1K and bringing the position to 46,965 shares worth $2.63M. The position accounts for 0.02% of the portfolio, ranked #575.

Park Avenue Securities first reported a position in RPRX in Q3 2025 and has held it in 4 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Park Avenue Securities held 46,965 shares of Royalty Pharma worth $2.63M as of Q2 2026.
  • Park Avenue Securities bought 1,117 Royalty Pharma shares in Q2 2026, an estimated $58.1K.
  • Royalty Pharma made up 0.02% of Park Avenue Securities's portfolio in Q2 2026, its #575 holding.
  • Park Avenue Securities first reported a position in Royalty Pharma in Q3 2025 and has held it in 4 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.